The company has received approval from the Drugs Controller General of India (DCGI) to manufacture and market Semaglutide ...

Sun Pharma receives DCGI approval to launch generic semaglutide injection, Noveltreat, for weight management in India.

India's top drug maker Sun Pharmaceutical Industries has announced today the launch of a generic version of semaglutide, the ...

Sun Pharmaceutical Industries announced that it has received approval from the Drugs Controller General of India (DCGI) to manufacture and market a generic version of semaglutide injection.

DCGI approval to Sun Pharma comes amid an ongoing patent dispute with Novo Nordisk in the Delhi High Court. The case relates ...

Sun Pharma receives DCGI approval to market generic semaglutide injection for chronic weight management in India. Launch after patent expiry.

Besides Sun Pharma, a growing roster of Indian drugmakers is lining up cheaper generic versions of semaglutide ahead of the ...

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated for weight management as an adjunct to a reduced-calorie diet and increased physical activity.

A recent report estimates that major US carriers could collectively save up to $580 million annually, thanks to the weight loss drugs ...

Use of the diabetes drug Ozempic for weight loss is rising. Understand the research, how it works, who should use it, and ...

Explore the benefits and side effects of popular weight loss drugs like Ozempic, Wegovy, Mounjaro, and Zepbound. Learn how ...

Monthly injections, once-daily pills, and even lifelong gene therapies could soon become options for people looking to lose ...